From the Journals

Initial HCV test results are false positive in almost half of general population


 

FROM JOURNAL OF CLINICAL VIROLOGY

Nearly half of patients in the general population who test positive for hepatitis C virus (HCV) do not have the disease, according to Dr. Anne Moorman and her associates.

From a sample of 22,359 National Health and Nutrition Examination Study participants, 479 people received positive HCV antibody test results from 2007 to 2012. Of this group, 477 participants underwent further follow-up testing using a recombinant immunoblot assay. RIBA testing confirmed positive test results for 323 participants, while 105 patients received negative test results and 49 received indeterminate test results.

Jarun011/Thinkstock
Samples from participants who received positive and indeterminate RIBA results were then tested using newer HCV RNA testing, which has replaced RIBA as an HCV confirmation test. Of the 278 samples that were RIBA positive tested for HCV RNA, 216 were positive, and 62 were negative. Of the 41 RIBA-indeterminate samples tested, 2 were positive and 39 were negative. Total positive HCV occurrence was 218 out of 424 fully tested NHANES participants.

“False-positive antibody assays may occur with great frequency, emphasizing the need for “reflex” HCV RNA testing to ascertain current infection status,” the investigators noted.

Find the full study in the Journal of Clinical Virology (doi: 10.1016/j.jcv.2017.01.007).

Recommended Reading

SNP predicts liver cancer in hepatitis C patients regardless of SVR
MDedge Family Medicine
Direct-acting antiretrovirals in genotype 1 HCV patients with mental health conditions safe, well tolerated
MDedge Family Medicine
Tumor boards linked to improved survival in hepatocellular carcinoma
MDedge Family Medicine
Sofosbuvir/velpatasvir improved patient-reported outcomes, knocked out HCV genotypes 1-6
MDedge Family Medicine
VIDEO: Appealing DAA denials is worth it for hepatitis C patients
MDedge Family Medicine
Hepatitis Outlook: October 2016
MDedge Family Medicine
Hepatitis Outlook: November 2016
MDedge Family Medicine
Hepatitis outlook: December 2016
MDedge Family Medicine
Prominent clinical guidelines fall short of conflict of interest standards
MDedge Family Medicine
VIDEO: Sofosbuvir with velpatasvir beat other HCV GT3 regimens
MDedge Family Medicine